Interestingly, we discovered through systematic screening for metastasis-associated DNA methylation changes mechanisms leading to downregulation of JAM3 expression in metastatic tumors, namely DNA hypomethylation at a distal ESR1 binding site and DNA hypermethylation of the gene promoter. This evidence concerns the gene JAM3 and metastatic neoplasm.